$MRK Headlines Planned layoffs up 13.5% in October:

New Post Public Reply Private Reply Replies (0) Message Board

Nov 6, 2013 at 8:35 PM

$MRK Headlines

Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Today - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 sales down to $11.03 bln vs. $11.49 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 profit falls to $1.12 bln vs. $1.73 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 EPS falls to $0.38 from $0.56 year ago 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Small caps surge, the year's best trading day and R.I.P. Lou Reed 6:37 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
The next big pharma 7:01 a.m. Oct. 25, 2013 - The Trading Deck

Boeing Will Make Key 777X Parts in Seattle and 2 Other Dow Movers to Watch 1:14 p.m. Today - Wall St. Cheat Sheet
Earnings Beat at Hospira in Q3, View maintained - Analyst Blog 12:27 p.m. Today - Zacks.com
Narrower-than-Expected Loss at Endocyte - Analyst Blog 10:50 a.m. Today - Zacks.com
Merck & Co Inc's Buy Recommendation Affirmed 9:00 a.m. Today - TheStreet.com
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Today - Wall St. Cheat Sheet
Bristol-Myers Not Done Climbing 6:30 a.m. Today - TheStreet.com
Cramer's Lightning Round - Alcoa Is Creeping Up (11/5/13) 6:09 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: ConocoPhillips Is Terrific 5:45 a.m. Today - TheStreet.com
7 Generous Dividend Stocks Giving Big Cash Back to Shareholders 1:00 a.m. Today - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: Got Growth? 8:27 p.m. Nov. 5, 2013 - TheStreet.com
3M Finalizes Asian Investments to Support Window Film and 2 Other Dow Movers to Watch 4:56 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Here’s How Pharma Stocks Are Outperforming the S&P 500 1:31 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Insider Trading Alert - OPK, ALGN, AREX, IBKR And MRK Traded By Insiders 2:10 p.m. Nov. 4, 2013 - TheStreet.com
DoJ Wants Divestments from US Airways, Amazon Preps ‘Alpha House,’ and 3 More Hot Stocks 12:58 p.m. Nov. 4, 2013 - Wall St. Cheat Sheet
Dow Today: Merck (MRK) Leads The Day Higher, E.I. Du Pont De Nemours & Company (DD) Lags 10:00 a.m. Nov. 4, 2013 - TheStreet.com
Analysts Comment on Merck's Hep C Regiment Advances 9:39 a.m. Nov. 4, 2013 - benzinga.com
Merck (MRK) Strong In Pre-Market Trading 8:38 a.m. Nov. 4, 2013 - TheStreet.com
Pfizer's Not Losing Its Kingpin Status 6:00 a.m. Nov. 4, 2013 - TheStreet.com
Merck: Why Oncology Smells Like Money 5:39 a.m. Nov. 4, 2013 - Seeking Alpha

Positive Clinical Data, Upcoming Presentations, and Completed Acquisitions - Research Report on Merck, Perrigo, Celgene, Cigna, and Boston Scientific 8:00 a.m. Today - PR Newswire
Merck Animal Health Launches Global Awareness Campaign to Support Pet Diabetes Month(TM) 6:42 p.m. Nov. 5, 2013 - PR Newswire
Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors 5:01 p.m. Nov. 5, 2013 - PR Newswire
InSite Vision Announces Appeal by Sandoz Inc. of Court Judgment Upholding All AzaSite(R) Patents in Patent Infringement Lawsuit 4:36 p.m. Nov. 5, 2013 - BusinessWire
Codexis Appoints Greg Hughes, Ph.D., as Vice President, Strategic Alliance & Product Development 4:01 p.m. Nov. 5, 2013 - BusinessWire
Surprising Earnings and News Updates: General Motors, BlackBerry, American International Group, First Solar, Merck & Co. 1:55 p.m. Nov. 4, 2013 - PR Newswire
Fitch: Pharmaceutical Cost Cutting Still Includes R&D for Some 11:18 a.m. Nov. 4, 2013 - BusinessWire
Presentation, Quarterly Reports, and FDA Approval - Research Report on Merck, United Therapeutics, Endo, Isis Pharmaceuticals, and Zogenix 8:00 a.m. Nov. 4, 2013 - PR Newswire
Merck's Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study 7:30 a.m. Nov. 4, 2013 - BusinessWire
Merck Announces Presentation of Interim Data from Study of Investigational Combination of HCV Therapies MK-5172 and MK-8742 at the 2013 American Association for the Study of Liver Diseases (AASLD) Annual Meeting 9:00 a.m. Nov. 2, 2013 - BusinessWire
Clinical Studies, Regulatory Clearance, Financial Results, and Approvals - Research Report on Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, AbbVie, and Novartis 9:00 a.m. Oct. 31, 2013 - PR Newswire
Merck Announces Presentation of Interim Data from Phase 1B Study of MK-3475, Investigational anti-PD-1 Immunotherapy, in Previously-Treated Patients with Non-Small Cell Lung Cancer (NSCLC) at 15th World Conference on Lung Cancer 1:15 a.m. Oct. 29, 2013 - BusinessWire
NQ, FIO, MRK and PBR added to NYSE Active Stock Watch List at GSR 10:55 a.m. Oct. 28, 2013 - ACCESSWIRE
EMD Serono and Open Monoclonal Technology Expand Collaboration to Include Unlimited Access to OmniRat(R) Human Antibody Platform 8:00 a.m. Oct. 28, 2013 - BusinessWire
Merck Announces Third-Quarter 2013 Financial Results 7:00 a.m. Oct. 28, 2013 - BusinessWire
ABLYNX TO PRESENT PRE-CLINICAL PROOF-OF-CONCEPT DATA ON ALX-0761 AT ACR 2:49 a.m. Oct. 28, 2013 - GlobeNewswire
ABLYNX TO PRESENT PRE-CLINICAL PROOF-OF-CONCEPT DATA ON ALX-0761 AT ACR 2:30 a.m. Oct. 28, 2013 - Thomson Reuters ONE
Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 10:12 a.m. Oct. 25, 2013 - PR Newswire
Merck Provides Update on Investigational 9-valent HPV Vaccine V503 to U.S. Advisory Committee on Immunization Practices 10:27 a.m. Oct. 24, 2013 - BusinessWire
ZOSTAVAX(R) (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product 7:30 a.m. Oct. 23, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Northwood's $375M Boost: Satellite Network Expansion

Northwood's Bold Leap into Space Connectivity Here's a nugget of info that could jolt your morning coffee: Northwood Space Corp—yeah, the folks linking satellites to Earth—just pulled in a whopping $375 million in Series C funding. This ain't your average capital injection; it's a full-throttle push to broaden their ground network reach and revamp space...

Potatoes vs. Candy: Halloween's Spuddy Surprise

When Halloween rolls around, you expect rabid kids clamoring for candy corn and chocolate bars. But this year, Idaho threw a spud into the sweets machine. Idaho's Potatoes Steal the Show In an unexpected twist, the Idaho Potato Commission ran a zany experiment on Halloween: kids had to choose between their beloved Halloween candy and a genuine Idaho potato. Imagine the...

Ceva's Wireless IP Dominance Amid AI Device Surge

Keeping the Wireless IP Crown Against All Odds Look, I've seen dominance play out in the markets over the years, but Ceva’s stranglehold on the wireless interface IP market is something fierce. They've got a whopping 68% market share, and folks, that’s 12 times their closest competitor. Talk about leaving the competition eating dust! For a field growing at a solid...

HashKey and RD Tech Partner for RDUSD Expansion

A Partnership with Serious Implications Here's a fresh duo in the financial frontier—HashKey On-Chain and RD Technologies are teaming up in a bid to push the RDUSD stablecoin into the heart of cross-border trade and finance. And why does it matter? Well, in the wild west of digital finance, stablecoins are the solid ground, and these two are planting their flag. It's a...

MetaOptics Expands U.S. Reach with ADR Programme

A Bold Move into the U.S. Market MetaOptics Ltd, the semiconductor optics dynamo out of Singapore, is kicking up some investment dust with their American Depositary Receipts (ADR) Programme aimed squarely at expanding its U.S. footprint. And let me tell you, in the game of international market expansion, that's no rookie maneuver. Why ADR? Why Now? So, why is MetaOptics...

Veteran Surge in 2026 Midterm Elections: A New Wave

A Swell of Veteran Candidates Hits the Midterm Shores Just when you think you've seen it all in politics, here comes another twist. As the 2026 midterms gear up, an impressive 258 military veterans are throwing their hats into the congressional ring. That's a jump up from 213 just two years back, and let me tell you, it's not just a numbers game—it's a sea change. Women...

YeePay's B2B Payment Innovations Target Airlines' Pain Points

A New Takeoff for Airline B2B Payments Dusting off the cobwebs of traditional payment processes, YeePay has been busy at the 2026 IATA WFS & WPS, held on the glitzy floor of the Galaxy International Convention Center in Macau from October 28 to 29. They're not just chatting about travel; they're rolling out a novel way to tackle the headaches in airline B2B order...

Investcorp's Strong 2026: A Deep Dive into Key Moves

Diving into Investcorp's Robust 2026 Performance If you're clued into the investment scene, you'll know that a $65.2 billion asset base isn't small potatoes. At the Gateway Gulf 2026, Investcorp didn't just present numbers—they laid out a dramatic year of action packed with billion-dollar dreams. While the dust hasn't quite settled yet, the first nine months of the year...

Target Hospitality Readies for Q3 2026 Earnings Reveal

The Thrill of Earnings Season Every trader worth their salt gets a tingle down the spine come earnings season. There's nothing quite like it—the build-up, the anticipation, the potential payouts. This time, we're zeroing in on Target Hospitality, bearing the ticker NASDAQ: TH. Come November 9, 2026, they're set to unveil what the past quarter had up its sleeve, and like...

Bahrain's USD 3.89 Billion Investment Surge in 2026

Bahrain's Bold Moves to Woo Global Investment Bahrain's never been one to tiptoe around, huh? With a whopping USD 3.89 billion on the line, the Kingdom's flashing its neon sign to investors: "Open for Business!" These Golden License projects aren't just a few shiny new ventures — they're bridging aviation logistics, real estate, and the tech sector. Talk about ambition....